Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Acta Physiol (Oxf) ; 201(4): 413-26, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20969729

ABSTRACT

AIM: At the interface of tissue and capillaries, pericytes (PC) may generate electrical signals to be conducted along the skeletal muscle vascular network, but they are functionally not well characterized. We aimed to isolate and cultivate muscle PC allowing to analyse functional properties considered important for signal generation and conduction. METHODS: Pericytes were enzymatically isolated from hamster thigh muscles and further selected during a 16-30 days' cultivation period. PC markers were studied by fluorescence activated cell scanning (FACS) and immunocytochemistry. Electrical properties of the cultured PC were investigated by patch clamp technique as well as the membrane potential sensitive dye DiBAC(4) (3). RESULTS: The cultured cells showed typical PC morphology and were positive for NG2, alpha smooth muscle actin, PDGFR-ß and the gap junction protein Cx43. Expressions of at least one single or combinations of several markers were found in 80-90% of subpopulations. A subset of the patched cells expressed channel activities consistent with a Kv1.5 channel. In vivo presence of the channels was confirmed in sections of hamster thigh muscles. Interleukin-8, a myokine known to be released from exercising muscle, increased the expression but not the activity of this channel. Pharmacologic stimulation of the channel activity by flufenamic acid induced hyperpolarization of PC alone but not of endothelial cells [human umbilical vein endothelial cells (HUVEC)] alone. However, hyperpolarization was observed in HUVEC adjacent to PC when kept in co-culture. CONCLUSION: We established a culture method for PC from skeletal muscle. A first functional characterization revealed properties which potentially enable these cells to generate hyperpolarizing signals and to communicate them to endothelial cells.


Subject(s)
Cell Separation/methods , Immunomagnetic Separation/methods , Muscle, Skeletal/cytology , Pericytes/cytology , Pericytes/physiology , Animals , Biomarkers/metabolism , Cells, Cultured , Connexin 43/metabolism , Cricetinae , Gap Junctions/metabolism , HeLa Cells , Humans , Interleukin-8/pharmacology , Kv1.5 Potassium Channel/metabolism , Membrane Potentials/physiology , Mesocricetus , Muscle, Skeletal/blood supply , Patch-Clamp Techniques , Pericytes/drug effects
2.
J Cell Physiol ; 188(1): 33-44, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11382920

ABSTRACT

Several papers report a hypoxia-induced upregulation of the endothelial nitric oxide synthase (eNOS) mRNA expression. Since there is no known hypoxia-sensitive element binding site in the eNOS promoter, we reasoned that the effect of hypoxia could be simulated by a metabolically elicited alteration of the redox state. Therefore, cultured porcine aortic endothelial cells (PAEC) were exposed to hypoxia (1-10% O(2)) or inhibitors of cellular energy metabolism including rotenone, 2, 4 dinitrophenol (DNP) and 2-deoxyglucose for 6 to 24 h. Additionally, cells were treated with lactate and nicotinic acid to alter the cellular NAD(P)H/NAD(P) ratio without changes of energy supply. The cellular NAD(P)H/NAD(P) ratio was used as an index of the cellular redox state and determined using the MTT-assay. Hypoxia increased eNOS mRNA transcription and MTT-reduction in a manner inversely proportional to pO(2). Exposure to rotenone, DNP, and lactate increased the NAD(P)H/NAD(P) ratio, MTT-reduction, and eNOS mRNA also in parallel. In contrast, 2-deoxyglucose and nicotinic acid attenuated both MTT-reduction and eNOS mRNA expression. In order to study a potential role of the redox regulated transcription factor complex AP-1 in hypoxia-induced eNOS mRNA transcription, c-jun expression was determined and decoy experiments were performed. c-jun expression paralleled changes of eNOS mRNA expression and MTT-reduction. Furthermore, in the presence of oligodeoxynucleotides corresponding to the AP-1 binding sites of the eNOS promoter, the hypoxia and chemically induced eNOS mRNA expression was completely abolished. We propose that hypoxia, by altering cellular metabolism, leads to an increase in the cellular NAD(P)H/NAD(P) ratio which favors enhanced eNOS expression by redox-sensitive AP-1 mediated transcriptional control.


Subject(s)
Cell Hypoxia , Endothelium, Vascular/enzymology , Nitric Oxide Synthase/metabolism , Oxygen/metabolism , Animals , Antimetabolites/pharmacology , Cells, Cultured , Dactinomycin/pharmacology , Deoxyglucose/pharmacology , Dinitrophenols/pharmacology , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Humans , Immunoblotting , Lactic Acid/pharmacology , Niacin/metabolism , Niacin/pharmacology , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type III , Nucleic Acid Synthesis Inhibitors/pharmacology , Oxidation-Reduction , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/metabolism , RNA, Messenger/metabolism , Rotenone/pharmacology , Swine , Transcription Factor AP-1/metabolism , Uncoupling Agents/pharmacology , Up-Regulation
3.
Br J Pharmacol ; 131(4): 667-72, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11030714

ABSTRACT

The physiological role of the angiotensin II AT2 receptor subtype is not fully characterized. We studied whether AT2 receptor could antagonize AT1 mediated superoxide formation in endothelial cells. In quiescent human umbilical vein endothelial cells (HUVEC) superoxide formation was measured after long-term incubation (6 h) with angiotensin II in the presence or absence of its receptor blocker candesartan (AT1) or PD123319 (AT2) using the cytochrome c assay. In separate experiments, the effects of AT2 mediated effects on activities of cellular phosphates including the src homology 2 domain containing phosphatases (SHP-1) was studied. The basal superoxide formation (0.19+/-0.03 nmol superoxide mg protein(-1) min(-1)) in HUVEC was increased by 37.1% after exposure to angiotensin II (100 nM,) which was due to an activation of a NAD(P)H oxidase. This was abolished by candesartan (1 microM) as well as the tyrosine kinase inhibitor genistein. In contrast, blockade of AT2 receptors by PD123319 enhanced the superoxide formation by 73.7% in intact cells. Stimulation of AT2 went along with an increased activity of tyrosine phosphatases in total cell lysates (29.8%) and, in particular, a marked stimulation of src homology 2 domain containing phosphatases (SHP-1, by 293.4%). The tyrosine phosphatase inhibitor vanadate, in turn, prevented the AT2 mediated effects on superoxide formation. The expression of both angiotensin II receptor subtypes AT1 and AT2 was confirmed by RT - PCR analysis. It is concluded that AT2 functionally antagonizes the AT1 induced endothelial superoxide formation by a pathway involving tyrosine phosphatases.


Subject(s)
Endothelium, Vascular/metabolism , Receptors, Angiotensin/physiology , Superoxides/metabolism , Cells, Cultured , Endothelium, Vascular/cytology , Enzyme Activation , Humans , Protein Tyrosine Phosphatase, Non-Receptor Type 1 , Protein Tyrosine Phosphatases/physiology , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2
4.
Acta Physiol Scand ; 168(4): 505-10, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10759587

ABSTRACT

Although it is generally assumed that small arterioles form the major site of vascular resistance, microcirculatory studies revealed that 40-55% of the total network resistance can reside in large arterioles and small arteries. Thus, the mechanisms that control smooth muscle tone in these vessels have a major impact on the overall conductance of the vascular network. These control mechanisms are different from those in small arterioles: Aside from an apparently reduced sensitivity to metabolites, the large resistance vessels are normally too far away from the capillary areas which they feed to be reached by diffusing metabolites from dependent cells within a reasonable period of time. Rather, recent intravital microscopic studies suggest that large resistance vessels are under tight control of endothelial factors such as nitric oxide and endothelium-derived hyperpolarising factor (EDHF). Nitric oxide opposes myogenic constrictions of large arterioles that potentially would impair tissue perfusion and oxygenation. Moreover, nitric oxide and EDHF play an important role in the co-ordination of large and small resistance vessel behaviour that is pivotal for the adaptation of blood flow to altered tissue oxygen demands.


Subject(s)
Arterioles/physiology , Endothelium, Vascular/physiology , Muscle, Skeletal/blood supply , Vasodilation/physiology , Animals , Humans , Regional Blood Flow/physiology , Vascular Resistance/physiology
5.
J Biol Chem ; 275(25): 18745-50, 2000 Jun 23.
Article in English | MEDLINE | ID: mdl-10764736

ABSTRACT

Superoxide anions impair nitric oxide-mediated responses and are involved in the development of hypertensive vascular hypertrophy. The regulation of their production in the vascular system is, however, poorly understood. We investigated whether changes in membrane potential that occur in hypertensive vessels modulate endothelial superoxide production. In cultured human umbilical vein endothelial cells, changes in membrane potential were induced by high potassium buffer, the non-selective potassium channel blocker tetrabutylammonium chloride (1 mm), and the non-selective cation ionophore gramicidin (1 micrometer). Superoxide formation was significantly elevated to a similar degree by all three treatments (by approximately 60%, n = 23, p < 0.01), whereas hyperpolarization by the K(ATP) channel activator Hoe234 (1 micrometer) significantly decreased superoxide formation. Depolarization also induced an increased tyrosine phosphorylation of several not yet identified proteins (90-110 kDa) and resulted in a significant increase in membrane association of the small G-protein Rac. Accordingly, the Rac inhibitor Clostridium difficile toxin B blocked the effects of depolarization on superoxide formation. The tyrosine kinase inhibitor genistein (30 micrometer, n = 15) abolished depolarization-induced superoxide formation and also prevented depolarization-induced Rac translocation associated with it. It is concluded that depolarization is an important stimulus of endothelial superoxide production, which involves a tyrosine phosphorylation-dependent translocation of the small G-protein Rac.


Subject(s)
Endothelium, Vascular/metabolism , Membrane Potentials/physiology , Superoxides/metabolism , rac GTP-Binding Proteins/physiology , Endothelium, Vascular/cytology , Endothelium, Vascular/enzymology , Enzyme Activation , Humans , NADPH Oxidases/metabolism , Phosphorylation , Protein Kinase C/metabolism , Tyrosine/metabolism
6.
Free Radic Res ; 32(3): 265-72, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10730825

ABSTRACT

Since an increased endothelial superoxide formation plays an important role in the pathogenesis of endothelial dysfunction its specific detection is of particular interest. The widely used superoxide probe lucigenin, however, has been reported to induce superoxide under certain conditions, especially in the presence of NADH. This raises questions as to the conclusion of a NAD(P)H oxidase as the major source of endothelial superoxide. Using independent methods, we showed that lucigenin in the presence of NADH leads to the production of substantial amount of superoxide (approximately 15-fold of control) in endothelial cell homogenates. On the other hand, these independent methods revealed that endothelial cells without lucigenin still produce superoxide in a NAD(P)H-dependent manner. This was blocked by inhibitors of the neutrophil NADPH oxidase diphenyleniodonium and phenylarsine oxide. Our results demonstrate that a NAD(P)H-dependent oxidase is an important source for endothelial superoxide but the latter, however, cannot be measured reliably by lucigenin.


Subject(s)
Acridines/pharmacology , NADH, NADPH Oxidoreductases/metabolism , NADP/metabolism , Superoxides/analysis , Arsenicals/pharmacology , Cells, Cultured , Cytochrome c Group/metabolism , Imidazoles/metabolism , Luminescent Measurements , NAD/metabolism , NADPH Oxidases , Neutrophils/enzymology , Onium Compounds/pharmacology , Pyrazines/metabolism , Umbilical Veins , Xanthine/metabolism , Xanthine Oxidase/metabolism
7.
J Biol Chem ; 274(23): 15996-6002, 1999 Jun 04.
Article in English | MEDLINE | ID: mdl-10347148

ABSTRACT

It has been suggested that the mechanical forces acting on endothelial cells may be sensed in part by cell-matrix connections. We therefore studied the role of different matrix proteins, in particular laminin I, on a shear stress-dependent endothelial response, namely nitric-oxide synthase (eNOS) expression. Primary porcine aortic endothelial cells were seeded onto glass plates either noncoated (NC cells) or precoated with fibronectin (FN cells), laminin (LN cells), or collagen I (CN cells). Western blots were used to detect differences in the final matrix composition of these cells. A shear stress of 16 dyn/cm2 was applied for 6 h. Only LN cells showed detectable amounts of laminin I in their underlying matrix when they reached confluence. They reacted with a 2-fold increase of eNOS expression (n = 16, p < 0.001) to the exposure of shear stress, which went along with enhanced eNOS protein and NO release. In contrast, neither FN cells (n = 9) nor NC cells (n = 13) showed a significant increase of eNOS expression under shear stress. The increase in CN cells was borderline (1.4-fold; n = 9, p < 0.05) and was not associated with an increase of eNOS protein. The shear-induced increase in eNOS expression of LN cells was abolished by the peptide YIGSR, which blocks the cellular binding to laminin I via a 67-kDa laminin-binding protein, whereas a control peptide (YIGSK) had no effect. The induction of eNOS expression by shear stress is stimulated by an interaction of endothelial cells with laminin which is, at least in part, mediated by a 67-kDa laminin-binding protein.


Subject(s)
Endothelium, Vascular/enzymology , Nitric Oxide Synthase/biosynthesis , Protein Precursors , Receptors, Laminin/physiology , Animals , Blotting, Western , Cell Adhesion , Cells, Cultured , Collagen/metabolism , Fibronectins/metabolism , Laminin/metabolism , Molecular Weight , Nitric Oxide Synthase Type III , Oligopeptides/pharmacology , Stress, Mechanical , Swine
8.
J Vasc Res ; 36(6): 456-64, 1999.
Article in English | MEDLINE | ID: mdl-10629421

ABSTRACT

The detection superoxide production in vascular cells is usually limited by a low sensitivity of available assays. We tested the applicability of the luminol derivate L-012 ¿8-amino-5-chloro-7-phenylpyridol¿3,4-dpyridazine-1,4(2H,3H)dione to measure superoxide production in cultured endothelial cells (human umbilical vein endothelial cells) and rat aortic segments. Following stimulation with the protein kinase stimulator phorbol 12-myristate 13-acetate (PMA, 1 microM) there was an 2.8-fold increase of L-012 chemiluminescence, whereas incubation with angiotensin II (100 nM) did not result in a measurable increase. Addition of vanadate (100 microM) considerably increased the chemiluminescence (up to 17-fold) after PMA and made possible the detection of an enhanced superoxide production after stimulation with angiotensin II (by 1.7-fold). This was due to a approximately 9-fold increase in signal intensity of L-012 in the presence of vanadate. Prolonged incubation with vanadate also led to a tyrosine phosphorylation-dependent increase in superoxide formation which was predominantly produced by an NAD(P)H oxidase. Short-term vanadate-enhanced L-012 chemiluminescence represents a highly sensitive assay making it possible to detect small changes of superoxide formation in intact vascular cells.


Subject(s)
Coloring Agents , Endothelium, Vascular/chemistry , Endothelium, Vascular/cytology , Luminol/analogs & derivatives , Superoxides/analysis , Humans , Luminescent Measurements , Umbilical Veins/cytology
10.
Gene Ther ; 3(2): 145-53, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8867862

ABSTRACT

Gene transfer with replication-deficient recombinant adenovirus (Ad) vectors may provide a novel approach to the treatment of some cardiac disorders. The relative efficiency of intramyocardial vs intracoronary Ad vector injection in transducing myocardial cells remains to be determined. Further, Ad vectors are associated with localized inflammation, and this could be associated with clinically significant side-effects. Female minipigs underwent open chest surgery and the Ad vector AdCMV.NLS beta-gal was injected into the circumflex coronary artery (IC; 2 x 10(10) p.f.u.; n = 5) or the posterobasal wall of the left ventricle (i.m.; 5 x 10(9) p.f.u., n = 4; 2 x 10(10) p.f.u., n = 18). The minipigs were killed after 2-31 days and the hearts examined for evidence of beta-galactosidase activity. Minipigs underwent epicardial echocardiography immediately before, within 15 min following the i.m. injection of AdCMV.NLS beta-gal and again at the time of death. Blood samples for white blood cell count, alkaline phosphatase, total bilirubin, blood urea nitrogen, creatinine and electrolytes were obtained before i.m. and i.c. injection of the Ad vector and before death. Intramuscular injection of the Ad vector was more efficient than i.c. infusion in infecting cells in a localized area of the heart. Myocardial beta-gal activity peaked at 3-6 days after i.m. injection and returned to its control value within 1 month. Although inflammatory cells were present at the injection site, echocardiograms did not show any evidence of either segmental or global left ventricular dysfunction. No minipigs died and all blood tests remained within normal limits following either i.m. or i.c. exposure to the Ad vector. In summary, direct i.m. administration of replication-deficient, recombinant Ad vectors provides a safe and effective approach for short-term gene transfer into the heart of large mammals.


Subject(s)
Adenoviruses, Human/genetics , Gene Transfer Techniques , Genetic Vectors/administration & dosage , Myocardium , Animals , Blood Chemical Analysis , Coronary Circulation , Female , Genetic Vectors/adverse effects , Genetic Vectors/genetics , Heart Ventricles , Injections, Intra-Arterial , Injections, Intramuscular , Leukocyte Count , Myocardium/chemistry , Myocardium/immunology , Swine , Swine, Miniature , beta-Galactosidase/analysis , beta-Galactosidase/genetics
11.
Int J Cancer ; 63(5): 673-9, 1995 Nov 27.
Article in English | MEDLINE | ID: mdl-7591284

ABSTRACT

Gene transfer techniques may provide efficient treatment for a variety of malignant neoplasms. A replication-deficient adenovirus (Ad) vector which carries the cDNA for wild-type p53 (AdCMV.p53) was tested for its in vitro and in vivo effects on the growth of murine melanoma cell line B16-G3.26 and human melanoma cell line SK-MEL-24. The growth of B16-G3.26 cells infected with AdCMV.p53 was inhibited when compared to the uninfected cells or cells infected with the control vector AdCMV.NLS beta gal. Similarly, the growth of SK-MEL-24 cells infected with AdCMV.p53 was also below that of AdCMV.NLS beta gal-infected and uninfected controls. DNA laddering using agarose gel electrophoresis and in situ labeling of DNA fragmentation (TUNEL) showed that AdCMV.p53-infected murine and human melanoma cells underwent apoptosis. Nude mice injected s.c. either with B16-G3.26 cells or with SK-MEL-24 cells developed localized tumors. These tumors were subsequently infiltrated with either AdCMV.p53, AdCMV.NLS beta gal or saline alone. One week after infection, B16-G3.26 tumors exposed to AdCMV.p53 were 2.5 times smaller than control tumors and exhibited DNA fragmentation. A similar growth-inhibitory effect of AdCMV.p53 was observed with SK-MEL-24 tumors. Thus, Ad-mediated wild-type p53 overexpression resulted in melanoma cell apoptosis and inhibition of melanoma growth in vitro and in vivo. These gene therapy approaches may be useful in targeting rapidly growing, malignant melanomas in a clinical setting.


Subject(s)
Adenoviridae/genetics , Apoptosis/physiology , Gene Transfer Techniques , Genes, p53 , Melanoma/genetics , Melanoma/pathology , Tumor Suppressor Protein p53/biosynthesis , Animals , Cell Division , DNA, Neoplasm/genetics , DNA, Neoplasm/metabolism , Gene Expression , Humans , Melanoma/therapy , Melanoma, Experimental/genetics , Melanoma, Experimental/pathology , Melanoma, Experimental/therapy , Mice , Mice, Nude , Neoplasm Transplantation , Tumor Cells, Cultured
12.
Acta Oncol ; 34(3): 435-8, 1995.
Article in English | MEDLINE | ID: mdl-7779437

ABSTRACT

We examined the potential of bFGF to function as a radioprotector of bone marrow (BM). Total intravenous doses of bFGF ranged from 1 to 24 micrograms/mouse, in 2 divided doses. Whole body radiation (WBI) was given in a single fraction to C3H mice. Histologic observations were performed on femur BM at various times after bFGF (or placebo) treatment. Thigh radiation in thigh-tumor bearing mice was delivered in a single fraction. bFGF increased the LD50/30 of mice in a dose dependent fashion, with an apparent maximum protection obtained with > or = 6 micrograms given half 24 h and half 4 h before irradiation. BM histology shows prominent recovery of megakaryocytes and all cell lineages along with less loss in cellularity compared to control irradiated animals. No radioprotection of RIF1 tumors after bFGF was detected. These results indicate that bFGF may be a selective radioprotector of normal tissue.


Subject(s)
Bone Marrow/radiation effects , Fibroblast Growth Factor 2/pharmacology , Fibrosarcoma/pathology , Neoplasms, Radiation-Induced/pathology , Radiation-Protective Agents/pharmacology , Animals , Bone Marrow/drug effects , Bone Marrow/pathology , Cell Division/drug effects , Cell Division/radiation effects , Cell Line , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Female , Lethal Dose 50 , Mice , Mice, Inbred C3H , Whole-Body Irradiation
13.
Eur J Biochem ; 213(2): 727-36, 1993 Apr 15.
Article in English | MEDLINE | ID: mdl-8477745

ABSTRACT

A fusion protein composed of about two vigilin domains and beta-galactosidase was used to raise polyclonal antibodies which were affinity-purified and employed for immunoblotting and immunohistochemistry. A protein of an apparent molecular mass of 155 kDa could be stained in extracts of a variety of cells from different species and organs. Immunohistological studies on single cells showed that vigilin is accumulated in the cytoplasm. During in vitro maintenance of primary cell cultures, as well as of a growth-factor-dependent cell line, vigilin expression decreases and ceases in senescent cells. In contrast, vigilin is constitutively expressed in all other transformed cell lines of various origin studies so far. Vigilin expression can be induced in peripheral blood lymphocytes by mitogen stimulation. These observations suggest an involvement of vigilin in processes of cell activation. Immunoblot experiments demonstrating the presence of vigilin in a broad range of eukaryotes, indicate a high degree of evolutionary conservation.


Subject(s)
Carrier Proteins , Cartilage/metabolism , Protein Biosynthesis , RNA-Binding Proteins , Animals , Cell Line , Cell Line, Transformed , Cells, Cultured , Chickens , Cytoplasm/metabolism , Electrophoresis, Polyacrylamide Gel , Humans , Immunoblotting , Lymphocyte Activation , Lymphocytes/metabolism , Proteins/chemistry , Proteins/isolation & purification , RNA, Messenger/analysis , RNA, Messenger/metabolism , Tumor Cells, Cultured
14.
Eur J Biochem ; 209(1): 321-8, 1992 Oct 01.
Article in English | MEDLINE | ID: mdl-1396708

ABSTRACT

Chicken vigilin was identified as a member of an evolutionary-conserved protein family with a unique repetitive domain structure. 14 tandemly repeated domains are found in chicken vigilin, all of which consist of a conserved sequence motif (subdomain A) and a potential alpha-helical region (subdomain B) [1]. We have established the physical structure of the chicken vigilin gene by restriction-fragment analysis and DNA sequencing of overlapping clones isolated from a phage lambda genomic DNA library. The chicken vigilin gene is a single-copy gene with a total of 27 exons which are distributed over a region of some 22 kbp. Exon 1 codes for a portion of the 5' untranslated region, exon 2 contains the translation start point and forms, along with exons 3 and 4, the N-terminal non-domain region. Exons 5-25 encode the vigilin domains 1-14 and the remaining exons 26 and 27 contain the non-domain C-terminal as well as the untranslated regions. The domain structure of the protein is reflected in the positioning of introns which demarcate individual domains. While domains 1-3 and 8-10 are each encoded by a single exon (5-7, 16-18); all other domains are contained in a set of two exons which are separated by introns interspersed at variable positions of the DNA segment coding for the conserved sequence motif. In conclusion, the data presented suggest that the chicken vigilin gene evolved by amplification of a primordial exon unit coding for the fundamental bipartite vigilin domain.


Subject(s)
Carrier Proteins , Chickens/genetics , DNA/chemistry , Exons , Gene Expression , Proteins/genetics , RNA-Binding Proteins , Animals , Base Sequence , Chick Embryo , Consensus Sequence , Cytosine/metabolism , Introns , Methylation , Molecular Sequence Data , Protein Biosynthesis , RNA, Messenger/analysis , Restriction Mapping , Tissue Distribution
15.
Eur J Biochem ; 206(3): 625-34, 1992 Jun 15.
Article in English | MEDLINE | ID: mdl-1606952

ABSTRACT

The complete cDNA (4375 bp), coding for a new protein called vigilin, was isolated from chicken chondrocytes. The cDNA shows an open reading frame of 1270 amino acids which are organized in 14 tandemly repeated homologous domains. Each domain consists of two subdomains, one with a conserved sequence motif of 35 amino acids (subdomain A) and another one with a presumptive alpha-helical structure of 21-33 amino acids (subdomain B). 149 amino acids at the N-terminus and 71 amino acids at the C-terminus of vigilin do not show the characteristic domain structure. No sequence characteristic of a signal peptide has been found, which argues for an intracellular localisation of vigilin. Vigilin is highly expressed in freshly isolated chicken chondrocytes but little in chondrocytes after prolonged time in culture. Vigilin mRNA exists in two size species, 4.4 kb and 6.5 kb in length due to the usage of different polyadenylation sites. Comparison of the vigilin sequence with data bases showed a remarkable similarity to protein HX from Saccharomyces cerevisiae [Delahodde, A., Becam, A. M., Perea, J. & Jacq, C. (1986) Nucleic Acids Res. 14, 9213-9214]. The yeast protein consists of eight homologous domains with 11 conserved amino acid residues within a set of 35 amino acids. The N-terminal and C-terminal regions of vigilin and protein HX do not reveal any sequence similarity. These results, together with the demonstration of the characteristic vigilin sequence motif in a human cDNA clone, suggest that the repeats represent evolutionary conserved autonomous domains within a family of proteins found in yeast, chicken and man.


Subject(s)
Carrier Proteins , Chickens/genetics , DNA/chemistry , Proteins/genetics , RNA-Binding Proteins , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cartilage/chemistry , Cartilage/embryology , Cells, Cultured , Chick Embryo , Cloning, Molecular , Humans , Molecular Sequence Data , Proteins/chemistry , RNA, Messenger/genetics , RNA, Messenger/isolation & purification , Repetitive Sequences, Nucleic Acid , Saccharomyces cerevisiae/chemistry , Sequence Homology, Nucleic Acid , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...